EMA committee recommends approval of Prolia for bone loss associated with glucocorticoid therapy April 30, 2018
INSYS initiates phase II study of cannabidiol oral solution for treatment of Prader-Willi syndrome April 30, 2018
FDA gives orphan drug designation to AMP-L2.7.D7 for congenital erythropoietic porphyria April 25, 2018
RSS